Connect with us
European Gaming Congress 2024

Artificial Intelligence

[New Report] Induced Pluripotent Stem Cells Market is estimated to be US$ 3.5 billion by 2032; Growing Prevalence of Diseases and Demand for Therapies to Foster Industrial Growth – By PMI

Published

on

Covina, June 28, 2023 (GLOBE NEWSWIRE) — “According to the latest research study, the demand of “Induced Pluripotent Stem Cells Market accounted for US$ 1.8 billion in 2022 and is estimated to be US$ 3.5 billion by 2032 and is anticipated to register a CAGR of 6.8%.

Induced Pluripotent Stem Cells (iPSC) are created by lentiviral or retroviral transduction. Beta islet cells for treating diabetes are example of Induced Pluripotent Stem Cells. Wide variety of uses in gene therapy and disease modelling have become major factor in market growth.

Presence of major key players and growing strategic partnerships and acquisitions has boost the demand for market growth. Growing prevalence of chronic diseases and improved healthcare infrastructure such as healthcare plans, presence of well advanced academic & research institutes has further facilitated the demand for Induced Pluripotent Stem Cells market growth.

What are the recent news in the Induced Pluripotent Stem Cells Market?

In June 2021, Catalent acquired RheinCell Therapeutics a German company and developer & manufacturer of GMP-grade human induced pluripotent stem cells for cell-based therapies. This acquisition will provide Catalent to strengthen its position in induced pluripotent stem cells market.

Advertisement
Attribute Details
Base year for estimation 2022
Forecast period 2022 – 2032
Accounted in 2022 US$ 1.8 billion
Estimated to be in 2032 US$ 3.5 billion
CAGR         6.8%
Market representation Revenue in USD Billion & CAGR from 2022 to 2032
Market Segmentation By Derived Cell Type – Neurons, Fibroblasts, Hepatocytes, Keratinocytes and Others.
By Application – Regenerative Medicine, Drug Development, Tissue Engineering, Toxicity Testing, Cell Therapy and Others
By End-Users – Research & Academic Institutes, Hospital & Clinics, Pharmaceutical Companies and Others
Regional scope North America – U.S., Canada
Europe – UK, Germany, Spain, France, Italy, Russia, Rest of Europe
Asia Pacific – Japan, India, China, South Korea, Australia, Rest of Asia-Pacific
Latin America – Brazil, Mexico, Argentina, Rest of Latin America
Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage Revenue forecast, company share, competitive landscape, growth factors, and trends

Click Here to Get Free Sample Copy of this Report@

https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/5121

What is Prophecy’s Analyst View on Induced Pluripotent Stem Cells Market?

Various applications of iPSC in drug delivery research by creating human BBD (blood-brain barrier) micro physiological system which includes, endothelial cells, and human astrocytes derived from iPSCs where scientists can significantly accelerate the research of neuro-pharmaceutical drug delivery transport and screening which has provided lucrative opportunities in market growth. Growing research & development activities and government funding has further, expected to boost the demand for Induced Pluripotent Stem Cells market growth.

What are the key drivers of growth in the Induced Pluripotent Stem Cells Market?

Advertisement

The Induced Pluripotent Stem Cells Market is driven by several factors that contribute to its growth and advancement. Here are some key drivers:

  • Disease modeling and drug discovery potential
  • Advancements in reprogramming techniques
  • Growing demand for personalized medicine
  • Potential for regenerative medicine applications
  • Collaborative research efforts
  • Supportive regulatory environment
  • Increasing investment and funding

What are the major challenges in the Induced Pluripotent Stem Cells Market?

The iPSCs market faces several significant challenges that impact its growth and development. These challenges include the need for improved reprogramming efficiency and reduced variability in iPSC generation. Ensuring safety and quality control is crucial, including minimizing genetic abnormalities and reducing the risk of tumorigenicity. Scalability and cost-effectiveness of iPSC production remain important considerations for widespread adoption.

Additionally, optimizing differentiation protocols to generate mature and functional cells, addressing intellectual property rights and patent issues, navigating complex regulatory landscapes, and addressing ethical considerations all pose challenges in the iPSCs market. Overcoming these challenges requires ongoing research, technological advancements, collaboration, and adherence to regulatory standards to advance the field and unlock the full potential of iPSCs.

Who are the key players or vendors in the Induced Pluripotent Stem Cells Market?

  • Lonza
  • Evotec SE
  • Thermo Fisher Scientific Inc.
  • Axol Bioscience Ltd.
  • Merck KGaA
  • Fate Therapeutics
  • Hitachi Ltd.
  • Cynata Therapeutics Limited
  • Applied StemCells Inc.
  • REPROCELLS Inc.

Download PDF Brochure:

https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/5121

Advertisement

What are the emerging trends and technologies in Induced Pluripotent Stem Cells Market?

Emerging trends and technologies in the Induced Pluripotent Stem Cells (iPSCs) market include advanced differentiation techniques for efficient and scalable production of mature cell types, gene editing technologies like CRISPR-Cas9 for precise genetic modifications, and the integration of artificial intelligence and machine learning for data analysis and prediction. Other trends include the use of organ-on-a-chip systems to mimic organ functionality, bioprinting and tissue engineering for creating complex tissue structures, and the application of automation and robotics to streamline iPSC generation and maintenance. These advancements have the potential to drive innovation, accelerate therapeutic discoveries, and expand the applications of iPSCs in regenerative medicine and drug development.

What are Key Benefits of Induced Pluripotent Stem Cells Market?

  • Disease modeling and understanding
  • Drug discovery and development
  • Personalized medicine applications
  • Potential for regenerative medicine
  • Ethical advantages compared to embryonic stem cells
  • Reduced risk of immune rejection in transplantation
  • Advancement of disease treatment and therapies
  • Commercial opportunities for research and industry growth
  • Precision medicine advancements based on individual genetic profiles

Key Questions Answered in Report:

  1. What is the current market size and projected growth rate of the Induced Pluripotent Stem Cells Market?
  2. What are the key factors driving the growth of the Induced Pluripotent Stem Cells Market?
  3. What are the major challenges and barriers in the Induced Pluripotent Stem Cells Market?
  4. What are the potential therapeutic applications of Induced Pluripotent Stem Cells Market and which diseases can be targeted?
  5. What are the emerging trends and technologies in Induced Pluripotent Stem Cells Market research and development?
  6. Who are the leading companies and academic institutions involved in the Induced Pluripotent Stem Cells Market?

Please Find Below Some Related Reports:

Stem Cell Assay MarketBy Type (Viability/Cytotoxicity, Isolation/Purification, Cell Identification, Proliferation, Cell Differentiation, Cell Function, and Cell Apoptosis Assays), By Kit (Adult Stem Cells Kit and Human Embryonic Stem Cells Kits), By Detection (Instruments and Detection Kits), By Instrument (Flow Cytometer, Micro Electrode Arrays, Cell Imaging Systems, and Automated Cell Counter), By Application (Regenerative Medicine And Therapy Development, Drug Discovery & Development, and Clinical Research), By End User (Government Research Institutes, Private Research, and Industry Research), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030

Synthetic Stem Cells Market – By Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030

Advertisement

Human Embryonic Stem Cells (HESC) Market – By Type (Totipotent Stem Cells, Pluripotent Stem Cells, and Unipotent Stem Cells), By Application (Research and Clinical Trials), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Trends, Analysis, and Forecast till 2029

Blog: www.prophecyjournals.com

Follow us on:

LinkedIn | Twitter | Facebook |YouTube 


Advertisement

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Xinhua Silk Road: E China’s Changzhou City unveils investment opportunities in sectors of new productive forces for global investors

Published

on

xinhua-silk-road:-e-china’s-changzhou-city-unveils-investment-opportunities-in-sectors-of-new-productive-forces-for-global-investors

BEIJING, Sept. 29, 2024 /PRNewswire/ — Changzhou City, an leading international smart manufacturing base located in east China’s Jiangsu Province, has released a bunch of investment investment opportunities to global investors in various sectors of new productive forces at the the 2024 New Energy Industry Development Conference & Invest in Changzhou Conference held in the city on September 19.

The investment opportunities covers nine areas including synthetic biology, low-altitude economy, intelligent connected new energy vehicles, solid-state batteries, hydrogen energy, third-generation semiconductors, and artificial intelligence, manifesting the confidence of Changzhou in further opening development. 
Changzhou, seated in the axis of the Yangtze River Delta, has become an important base for advanced manufacturing in China.
In recent years, thanks to intensified efforts in developing new energy industry and fostering new quality productive forces, Changzhou has expanded the added value of its industrial sector to more than two trillion yuan, with manufacturing added value accounting for about 43 percent, both ranking among the top three in Jiangsu Province.
In the Hurun China New Energy Cities 2024, a list released by the Hurun Research Institute at the conference, Changzhou ranked first among other cities in the country for three consecutive years in terms of investment attractiveness and concentration.
Changzhou has accumulated a total of 10.59 billion US dollars (nearly 74.25 billion yuan) in terms of actually utilized foreign capital since 2020. Major projects such as soft magnetism of ArcelorMittal and medical device of BIOS, a Hong Kong-based company, have been launched during the conference. 
In addition, Changzhou has released a multilingual guide for foreign nationals in Changzhou at the conference, which includes practical service items in stay and residence, work, convenient payment options, among others, turning the city into a more open and international place.
Original link: https://en.imsilkroad.com/p/342380.html
Photo – https://mma.prnewswire.com/media/2518604/Changzhou.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/xinhua-silk-road-e-chinas-changzhou-city-unveils-investment-opportunities-in-sectors-of-new-productive-forces-for-global-investors-302261868.html

Continue Reading

Artificial Intelligence

CGTN: China honors individuals with highest awards in celebration of 75th National Day

Published

on

cgtn:-china-honors-individuals-with-highest-awards-in-celebration-of-75th-national-day

BEIJING, Sept. 29, 2024 /PRNewswire/ — Huang Zongde enlisted in the Chinese People’s Liberation Army at the age of 17, beginning a nearly four-decade-long military career where his bravery, valor and devotion earned him countless awards and honors.

The heavily decorated 93-year-old received the highest state honor on Sunday when Chinese President Xi Jinping conferred him with the Medal of the Republic at a ceremony in the Great Hall of the People in Beijing.
China awarded national medals and national honorary titles to 15 individuals, including Huang, in recognition of their contribution and achievement as it celebrates the 75th anniversary of the founding of the People’s Republic of China, which falls on October 1.
Chinese heroes and role models
In addition to Huang, three others were awarded the Medal of the Republic. Wang Yongzhi, a missile and rocket expert and a pioneer of China’s manned space program, was honored posthumously. Wang Zhenyi, a medical scientist known for breakthroughs in leukemia treatment, and Li Zhensheng, an expert in wheat breeding, are also among the honorees.
The national honorary titles went to 10 people, including scientists, a border patrolman, an artist, a craftsman, educators, a health worker, an economist and an athlete.
Addressing Sunday’s awarding ceremony, President Xi, also general secretary of the Communist Party of China Central Committee and chairman of the Central Military Commission, called on the Chinese people to learn from heroes and role models to form a mighty force to build a strong China.
China is in a crucial period for building a great modern socialist country in all respects and achieving national rejuvenation through Chinese modernization, he said.
Encouraging the Chinese people to strive for extraordinary achievements at ordinary job posts, Xi urged them to contribute to resolving challenges to development and reform and safeguarding social harmony and stability.
China’s old friends and good friends
As its highest state honor for foreigners, China awarded the Friendship Medal to Dilma Rousseff, president of the New Development Bank and former Brazilian president, for her commitment to the friendship between China and Brazil, and development of relationship between China and the Community of Latin American and Caribbean States, and cooperation among BRICS countries, a group of major emerging economies.
Accepting the honor at the ceremony, Rousseff said the medal symbolizes the strong bonds between Brazil and China and pledged to continue her unremitting efforts to promote the friendship.
China’s achievements over the decades, including economic transformation, technological innovation and remarkable social development, have made it a beacon and a source of inspiration for the world, she said.
Xi lauded Rousseff as an outstanding representative of China’s old friends and good friends who have shared the same aspirations and stood together with the Chinese people over the past 75 years and vowed that China will never forget such international friends.
The Chinese people are ready to join hands with people from all over the world to safeguard world peace, promote common development and advance the building of a community with a shared future for mankind to create a better future for humanity, he said.
https://news.cgtn.com/news/2024-09-29/China-honors-individuals-with-highest-awards-ahead-of-National-Day-1xhS1SaZeZa/p.html
 

View original content:https://www.prnewswire.co.uk/news-releases/cgtn-china-honors-individuals-with-highest-awards-in-celebration-of-75th-national-day-302261867.html

Continue Reading

Artificial Intelligence

Kazakhstan Government Delegation Visited SUPCON

Published

on

kazakhstan-government-delegation-visited-supcon

HANGZHOU, China, Sept. 29, 2024 /PRNewswire/ — On September 26, a delegation from the Ministry of Digital Development, Innovations and Aerospace Industry of the Republic of Kazakhstan, led by Minister Madiyev Zhaslan, visited SUPCON. SUPCON’s Chairman and President, Mr.Cui Shan, warmly welcomed the delegation.

The Kazakhstan government representatives expressed their appreciation and recognition of SUPCON’s expertise and innovation in intelligent manufacturing, digital transformation, and industrial AI.
Madiyev Zhaslan expressed a strong interest in industrial AI technologies of SUPCON, particularly their applications in intelligent and low-carbon facilities. He looks forward to exploring extensive collaboration with SUPCON across various sectors in Kazakhstan.
Cui Shan emphasized that as a leading industrial AI company with a global presence, SUPCON will leverage its technological advantages to meet Kazakhstan’s industry development requirements and trends, injecting new momentum into the country’s industrial digitalization.
In 2023, SUPCON established a subsidiary in Kazakhstan as its Central Asia regional headquarters and set up a localized operational system. SUPCON will continue to invest in the long-term development of the Central Asia region, contributing further wisdom and strength to the industrial digital transformation in Kazakhstan and beyond.
Photo – https://mma.prnewswire.com/media/2518470/image_5022684_18905906.jpg Photo – https://mma.prnewswire.com/media/2518471/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/kazakhstan-government-delegation-visited-supcon-302261857.html

Continue Reading

Trending